Scienture (SCNX) Stock: Buy, Sell, or Hold?
SCNX - Scienture Holdings, Inc. Common Stock
$0.16
-0.02 (-10.33%)
▼
5d:
-42.75%
30d:
-57.08%
90d:
-54.02%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When SCNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SCNX is down 42.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SCNX is down 42.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SCNX is currently trading at $0.16, which is considered oversold relative to its 30-day fair value range of $0.27 to $0.39.
Technical Outlook: Technically, SCNX is in a downtrend. Immediate support is located at $0.13, while resistance sits at $0.35. Short-term momentum is weak, with the stock down 10.3% recently.
Market Sentiment: SCNX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.50 (+844.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SCNX is in a downtrend. Immediate support is located at $0.13, while resistance sits at $0.35. Short-term momentum is weak, with the stock down 10.3% recently.
Market Sentiment: SCNX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.50 (+844.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.27 -
$0.39
Company Quality Score
40/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-10.3%)
- BULLISH: Trading 844.6% below Wall St target ($1.50)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.27 -
$0.39
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$0.35
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.83
Wall Street Target
$1.50
(+844.6%)
Revenue Growth (YoY)
449.1%
Share & Embed Analysis
Last updated: October 04, 2026 1:18 AM ET
Data refreshes hourly during market hours. Next update: 2:18 AM
Data refreshes hourly during market hours. Next update: 2:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Pharmaceutical Retailers Stocks
Top-rated stocks in Pharmaceutical Retailers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HITI
High Tide Inc |
STRONG BUY
5 analysts |
$5 | 52 HOLD |
